RecruitingNCT07527403

Impact of Theta Burst Repetitive Transcranial Magnetic Stimulation on the Patient's Self-reported Improvement in Their Motor Functional Neurological Disorder


Sponsor

Hospital Center Guillaume Régnier

Enrollment

22 participants

Start Date

Mar 13, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Functional neurological disorder (FND) is a condition that causes significant suffering and disability. It is defined by the presence of neurological symptoms that interfere with an individual's functioning and are not consistent with any known anatomical lesion but that causes significant functional impairment. The investigators are particularly interested in motor symptoms (abnormal movements or motor deficits). Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and acceptable treatment that has proven effective in certain chronic pain conditions, depression, and OCD. The investigators would like to evaluate the impact of rTMS on the patient's overall perception of change, particularly on the clinical symptoms of motor FND. Secondary objectives include evaluating the overall effect on symptoms from the clinician's perspective, the effect on quality of life, on depressive and anxiety symptoms and associated dissociation, as well as evaluating any changes in the sense of agency and identifying the side effects of rTMS treatment.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients over 18
  • Patients with FND, either deficits or abnormal movements, diagnosed by a neurologist.
  • Patients with an indication for validated neuronavigated rTMS treatment.
  • Patients who have indicated that they do not object to participating in the study.

Exclusion Criteria2

  • Patients subject to legal protection (legal guardianship, conservatorship, trusteeship)
  • Patients deprived of liberty

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERtheta-burst rTMS (repetitive transcranial magnetic stimulation)

Patients receive 40 sessions of intermittent theta burst stimulation of the right TPJ over 10 days (4 sessions per day). The right TPJ is located using neuronavigation.


Locations(1)

Centre Hospitalier Guillaume Régnier

Rennes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07527403


Related Trials